Artificial Intelligence

Artificial intelligence, or AI, is an umbrella term for machine learning and deep learning. It is where a machine takes in information from its surroundings and, from that, makes the most optimal decision appropriate to the situation.

AI in Food: How Artificial Intelligence is Designing Healthier and More Sustainable Foods

Artificial intelligence is transforming food innovation by accelerating ingredient discovery, optimizing formulations, and enabling personalized nutrition strategies to improve public health outcomes. AI-driven tools also support food safety assessment, sustainable food systems, and precision nutrition while raising important governance, equity, and validation challenges.

Recent Developments in Health Technology

How Artificial Intelligence Is Revolutionizing Emergency Medicine

Machine Learning in Drug Development

AI Psychosis: How Artificial Intelligence May Trigger Delusions and Paranoia

The Role of AI in Pathogen Detection and Epidemic Prediction

What does ChatGPT mean for Healthcare?

Is Data at the Center of Healthcare for the Future?

Can Artificial Intelligence be used to Diagnose Brain Aneurysms?

Ethical Considerations in AI-Driven Healthcare

Artificial Intelligence in Cardiology

Artificial Intelligence and Deep Learning in Medicine

See more featured articles »

Managing the Explosion of Healthcare Data to Harness its Power

Deep-Learning in Radiology

Applying Deep Learning to Localization Microscopy

Beyond Virtual Consultations: The Rise of AI-Driven Virtual Healthcare Assistants

Artificial Intelligence in CBT

The Pros and Cons of Healthcare Chatbots

AI-Powered Genomic Analysis: Revolutionizing the Detection of Genetic Mutations

Artificial Intelligence in Histopathology

Uncovering the Mystery of the Human Brain with Computational Neuroscience

The Medical Industries That Are Most Likely to Be Impacted by Ai

Artificial Intelligence and Life Science

Latest Artificial Intelligence News and Research

Recruitment begins for 600 future medical researchers

Through a £90 million Medical Research Council (MRC) investment, researchers will undertake PhDs and get experience in academia, healthcare and industry.

26 Sep 2026

AI-based model predicts glioblastoma recurrence to guide targeted treatment

A new AI-based model can predict where glioblastoma is most likely to return after initial surgery, potentially giving doctors a chance to treat it before it becomes visible on MRI.

25 Sep 2026

AI could expand affordable tuberculosis screening in rural Philippines

In the Philippines, public healthcare remains inaccessible to many due to a variety of factors, including the high cost and limited availability of medical experts.

25 Sep 2026

Emerging therapies expand the treatment landscape for coronary artery disease

Announcing a new article publication for Cardiovascular Innovations and Applications. Coronary artery disease (CAD) remains the leading cause of death globally, despite the limited efficacy of current pharmacological therapies.

25 Sep 2026

AI correction tone influences effectiveness in combating medical misinformation

At a time of rampant medical misinformation online, artificial intelligence can do a good job of correcting falsehoods, but the tone of the correction is key, according to new research led by Washington State University.

25 Sep 2026

In vivo CAR-T therapy transforms customized treatments into universal medicines

A collaborative team led by Professor Huji Xu from Naval Medical University, China, together with Professors Xuanming Yang and Yujia Cai at Shanghai Jiao Tong University, China, published a comprehensive review in Volume 2, article number 33 of the journal Immunity & Inflammation on August 31, 2026.

25 Sep 2026

Leica Biosystems brings Tempus pathology products to Aperio AI Store, accelerating AI-powered capabilities for oncology research

The Aperio AI Store integrates Tempus' AI applications, transforming complex pathology images into research insights and accelerating cancer diagnostics.

From Leica Biosystems 25 Sep 2026

AI model predicts immunotherapy-related pneumonitis risk from CT scans

Researchers at The University of Texas MD Anderson Cancer Center have developed an artificial intelligence (AI) model that can identify lung cancer patients at increased risk of developing a serious immunotherapy-related side effect before treatment begins, offering a possible path toward more personalized monitoring and prevention strategies.

24 Sep 2026

Mount Sinai researchers discover how Alzheimer's gene damages blood vessels

Mount Sinai researchers have identified how APOE4, the strongest genetic risk factor for Alzheimer's disease, damages the brain's blood vessels and promotes the buildup of abnormal proteins linked to neurodegenerative disease.

24 Sep 2026

NSF awards $19 million to build 3D biological observatory for revealing life's smallest structures

How does learning change the wiring of your brain? How does a shark's eye make sense of its underwater world? How does a single-celled parasite cross the barrier that protects the brain? What might neurodegeneration look like at ultra-magnified scale?

24 Sep 2026

AI tool provides early warning for organ failure in acute pancreatitis

Acute pancreatitis (AP) is one of the most common acute digestive disorders worldwide, and its most feared complication-persistent organ failure-drives mortality rates of 30% to 50%.

24 Sep 2026

Advances in chemistry and delivery are taking oligonucleotide medicines beyond rare diseases

A review in Cell Reports Medicine examines how advances in oligonucleotide chemistry and delivery have established ASOs and RNA interference therapies as a class of genetic medicines, with 21 oligonucleotides approved at the time of writing. It also identifies extrahepatic delivery, safety, target validation, individualized treatment, and data quality as priorities as the field expands into common diseases and explores AI-assisted development.

24 Sep 2026

Forge Nano and Nanexa enter joint development agreement to advance manufacturing for ALD-coated PharmaShell® long-acting injectable medicines

Forge Nano, Inc., a leading U.S.-based semiconductor equipment and advanced materials company pioneering Atomic Layer Deposition ("ALD") technology for artificial intelligence ("AI")-era chip manufacturing and defense battery applications, which has signed an agreement to merge with Archimedes Tech SPAC Partners II Co. ("Archimedes II"), today announced a Joint Development Agreement ("JDA") with Nanexa AB to develop scalable pharmaceutical manufacturing capabilities for Nanexa's PharmaShell® drug delivery platform and its portfolio of proprietary and partnered programs.

From Forge Nano 23 Sep 2026

PsychAD studies map molecular mechanisms across major brain disorders

Research led by Mount Sinai scientists within the PsychAD Consortium, a large-scale, multidisciplinary initiative launched in 2019 with support from the National Institute on Aging (NIA), is featured in a landmark collection of nine papers published across the Nature family of journals that maps the molecular mechanisms underlying Alzheimer's disease, Parkinson's disease, schizophrenia, and other brain disorders.

23 Sep 2026

New AI tool detects signs of endometriosis in milliseconds

Less than a second. That's how long it takes for an emerging AI tool to detect signs of endometriosis through one simple scan.

23 Sep 2026

DePuy Synthes showcases next-generation trauma innovations at OTA 2026

DePuy Synthes, a global leader in orthopedic technologies and solutions, will showcase its latest trauma innovations at the 2026 Orthopaedic Trauma Association (OTA) Annual Meeting in Nashville, including four new VOLT™ plating systems, MAXFRAME AUTOSTRUT™ with Bluetooth® Multi-Axial Correction System, VELY™ Trauma AI Assisted Surgery enabling technology, and an expanded value offering for procedural solutions.

23 Sep 2026

New AI tool predicts hydrogen positions to speed up drug discovery

New York University researchers have trained an AI model to learn chemical patterns associated with stability in drug-like molecules and accurately predict where their hydrogen atoms should be positioned.

23 Sep 2026

Cancer-related DNA changes may appear in blood years before diagnosis

Researchers found that genome-wide plasma cfDNA methylation profiles collected before diagnosis contained early molecular signatures associated with future prostate and breast cancer, with prostate silencer methylation providing the stronger risk stratification. Breast enhancer signals were weaker and varied by subtype and disease stage, indicating that cfDNA methylation may have greater value for risk assessment and surveillance than as a standalone diagnostic test.

23 Sep 2026

New scanning method detects basal cell carcinoma early using AI

Researchers at FAU combine optical diagnosis method with AI-assisted image recognition.

22 Sep 2026

Binghamton University scientists win seed funding for medical technologies

Two Binghamton University faculty members will receive seed funding through the State University of New York (SUNY) Technology Accelerator Fund (TAF), which provides grants to faculty inventors and scientists.

22 Sep 2026